Hematopoietic Cell Transplantation–Specific Comorbidity Index Predicts Inpatient Mortality and Survival in Patients Who Received Allogeneic Transplantation Admitted to the Intensive Care Unit In all, ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Arsenic Trioxide Injection in a 10 mg per 10 mL vial presentation. The product is ...
Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of arsenic trioxide (Oral-ATO; ARSENOL) for the treatment of acute promyelocytic ...
All-trans retinoic acid (ATRA) with chemotherapy is the standard of care for acute promyelocytic leukemia (APL), resulting in cure rates exceeding 80%. Pilot studies of treatment with arsenic trioxide ...
Early studies indicate oral arsenic trioxide provides similar systemic exposure to IV dosing. The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation ...
Trial of Arsenic Trioxide Finds the Drug is Safe and Effective as a Short-Course Treatment for Lupus
Newly published data from a phase IIa drug trial shows the treatment arsenic trioxide (ATO) showed positive results for people with lupus. Initial findings also show encouraging efficacy results for ...
With a median follow-up of 53 months, the event-free survival rate at 50 months among the 156 patients in the intention-to-treat analysis was 96% (95% confidence interval [CI], 92 to 100) in the ...
For over 2,400 years, arsenic — from the Greek word arsenikon, meaning “potent” — has been used as both a therapeutic agent and a poison. During their time, Hippocrates used the arsenic sulfides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results